BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:The past twelve months have culminated in an unprecedented lev el of excitement\, investment\, and clinical progress within the gene the rapy field. As the field strives to strike a delicate balance between saf ety and efficacy\, in the context of increased regulatory scrutiny and sa fety challenges\, attending the 4th Annual Gene Therapy Analytical Develo pment as an analytical scientist has never been so important.\n\nThis yea r's summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech\, pharma and academia to continue to develop resil ient\, long-lasting and robust analytical tools to enhance the safety\, q uality and efficacy of gene therapy products.  \;\n\nWhether you are focusing on specific characterization methods\, enhancing your genome seq uencing\, advancing your understanding of full and partial particles\, or advancing your early-stage bioassays\, with 4 tracks\, 8 pre-conference workshops and a post-conference focus day\, the 4th Gene Therapy Analytic al Development Summit will encompass all aspects of analytical developmen t\, giving you the chance to address and overcome challenges.\n\nIf you w ork in quality control\, quality assurance\, or process development - we' ve listened and we've answered. This year's agenda includes a novel track designed for quality control and process development groups working in g ene therapy. Talks include enhancing the knowledge transfer between depar tments\, bridging between analytical methods with regards to QC/PD\, and enhancing in-process development support.\n\nWhether you're working with AAV\, non-viral vectors or lentiviral vectors\, this is your opportunity to enhance your existing analytical methods and explore innovative new to ols to support safe and effective gene therapy development.\n\nURLs:Ticke ts: https://go.evvnt.com/1259027-2?pid=185Brochure: https://go.evvnt.com/ 1259027-3?pid=185\n\nPrices:2 Day Conference Only - Drug Developer: USD 2 999.00\,2 Day Conference + Workshop Day OR Discussion Day - Drug Develope r: USD 3997.00\,FULL ACCESS PASS: 2 Day Conference + Workshop Day AND Dis cussion Day - Drug Developer: USD 4995.00\,2 Day Conference Only - Standa rd : USD 3999.00\,2 Day Conference + Workshop Day OR Discussion Day - Sta ndard : USD 4997.00\,FULL ACCESS PASS: 2 Day Conference + Workshop Day AN D Discussion Day - Standard : USD 5995.00\n\nSpeakers: Adebowale Shoroye\ , Scientist\, Biogen\, Alexander Wong\, Principal Research Associate\, Sa nofi Genzyme\, Andrea Hamilton\, Associate Director\, Quality Control\, G yroscope Therapeutics\, Andrea Sobjack\, Associate Director\, Janssen Res earch and Development\, Anthony Leyme\, Principal Scientist\, Analytical Development\, Elevate Bio\, Bernice Yeung\, Senior Director\, Head of Ana lytical Development\, Biogen\, Bryan Troxwell\, Director\, Stride Bio\, C onnie Tsai Associate Director\, Analytical Development\, Novartis Gene Th erapies\, Courtney Sloan\, Principal Scientist and Group Leader\, Pfizer\ , Craig Jerome\, Analytical Development/ Quality Control Associate\, AGTC \, Cullen Mason\, Associate Director\, Head of Gene Therapy and Assay Dev elopment\, Biogen\, David Dobnik\, Senior Research Associate\, National I nsitute of Biology\, Debashree Basu\, Senior Scientist\, Analytical Devel opment\, Ultragenyx\, Dwayne Neal\, Senior Director\, Analytical Sciences and Technology\, AVROBIO\, Elena Peletskaya\, Director\, Gene Delivery A nalytics\, BMS\, Felipe Gazos-Lopes\, Associate Director for Analytical D evelopment\, Tessera Therapeutics\, Gary Li Director\, Quality Control\, Capsida Inc.\, Graham Whyteside\, Senior Director\, Platform Development\ , AskBio\, Huimin Tao\, Principal Scientist\, Analytical Development\, No vartis Gene Therapies\, Ilya Shestopalov\, Senior Director\, Analytical P roduct Lead\, bluebird bio\, Jarrod Dean\, Associate Director\, NGS Leade r\, Genomics Medicine Unit CMC\, Sanofi\, Jessica Gee\, Research Associat e\, Sangamo Therapeutics\, Jing Zhu Director\, Process and Analytical Dev elopment\, RVAC Medicines\, Joseph Schroer\, Engineer\, Genentech\, Kamil a Pytel\, Associate Director\, CMC Analytical Development\, Gyroscope The rapeutics\, Kinnari Patel\, President and COO\, Rocket Pharmaceuticals\, Lamine Bouakaz\, Global Head Cell and Gene Product Supply\, Santen\, Mari na Feschenko\, Senior Director\, Analytical Development\, Intergalactic T herapeutics\, Matthew Blackburn\, Senior Scientist\, Assay Development\, Abeona Therapeutics\, Matthew Sampson\, Manager\, QC Gene Therapy Analyti cal Technology\, Biogen\, Monica Terraro\, Senior Scientist\, CSL Behring \, Nathalie Clement\, Consultant\, Unicorn Consultants\, Pavlina Wolf\, S enior Scientist\, Editas Medicine\, Peter Clarner\, Gene Therapy Accelera tor and Unit Scientist\, Biogen\, Ronald Toth Senior Scientist\, Characte rization  \;Sanofi\, Ruth Frenkel\, Scientist II\, Analytical Develop ment\, Biogen\, Santoshkumar Khatwani\, Director\, Analytical Development \, Sangamo Therapeutics\, Sarah Dickerson\, Senior Scientist\, Process An alytics\, Umoja Biopharma\, Scott Burger\, Principal\, Advanced Cell and Gene Therapy\, Srihariraju Mulagapati\, Senior Scientist\, AstraZeneca\, Susan Sleep\, Director\, Assay Development\, AGTC\, Tom Colace\, Director \, LNP Process Development\, Tessera Therapeutics\, Tushar Patel\, Direct or\, Analytical Development\, Vedere Bio II\, Wei Zhang\, Associate Direc tor\, Analytical Development\, Ultragenyx Pharmaceuticals\, Wei-Chiang\, Chen BioProcess Analytics\, Genomic Medicine Unit\, Sanofi\, William Wern er\, Senior Director\, Analytical Assay Development\, Audentes Therapeuti cs\, Xiaoying Jin\, Head of GMU BioAnalytical Characterization\, Sanofi\, Yiling Bi\, Scientist III\, Analytical Development\, Sangamo Therapeutic s\, Judit Bartalis\, Senior Scientist\, Novartis Gene Therapies\, Zhijie Wu\, Scientist\, Regeneron\, Sachin Thakkar\, Staff Scientist\, Bayor Col lege of Medicine\, Stuart Nelson\, Senior Analytical Scientist\, Prevail Therapeutics\n DTEND:20221201T180000 DTSTAMP:20260307T153117Z DTSTART:20221128T090000 LOCATION:The Westin Boston Seaport District\, 425\, Summer Street\, Boston \, Suffolk County\, 02210\, SEQUENCE:0 SUMMARY:The past twelve months have culminated in an unprecedented level o f excitement\, investment\, and clinical progress within the gene therapy field. As... UID:986c653c-3317-40bb-aec4-e6a11e624714 END:VEVENT END:VCALENDAR